PRLX 93936 Uses, Dosage, Side Effects and more

PRLX 93936 is selectively toxic to cancer cells.

PRLX 93936 shows robust and selective toxicity in a wide variety of tumor cell-lines, and causes complete tumor regression in mouse xenograft models of fibrosarcoma, pancreatic cancer, ovarian cancer, colon cancer, and melanoma.

Trade Name PRLX 93936
Generic PRLX 93936
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Uses

Investigated for use/treatment in solid tumors.

How PRLX 93936 works

PRLX 93936 appears to inhibit mitochondrial outer membrane protein VDACs (voltage-dependent anion channels) 2 and 3, resulting in an oxidative, non-apoptotic cell death.

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share